RESMED INC — Director's Dealing 2022

Nov 16, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2022-11-15

Reporting Person: Douglas Robert Andrew (President and COO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-11-15	ResMed Common Stock	M	1144	$58.24	Acquired	34578	Direct
2022-11-15	ResMed Common Stock	M	16888	$58.24	Acquired	51466	Direct
2022-11-15	ResMed Common Stock	S	11280	$222.0691	Disposed	40186	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-11-15	ResMed Common Stock Options	$58.24	M	1144	Disposed	2022-11-19	ResMed Common Stock (1144)	Direct
2022-11-15	ResMed Common Stock Options	$58.24	M	16888	Disposed	2022-11-19	ResMed Common Stock (16888)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
ResMed Common Stock	227708	Indirect

Footnotes

F1: The transaction was conducted under a Rule 10b5-1 plan.

F2: This transaction was executed in multiple trades at prices ranging from $221.77 $223.56. The price reported above reflects the weighted average sale price.

F3: Represents date options first became exercisable. Options vest 1/3 per year.